Pathophysiology of Influenza A Virus-induced Lung Injury in Juveniles
甲型流感病毒引起的青少年肺损伤的病理生理学
基本信息
- 批准号:10208942
- 负责人:
- 金额:$ 16.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-06 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAdolescentAdultAdult Respiratory Distress SyndromeAgeAlveolar MacrophagesAnimal ModelAntibodiesAntiviral AgentsAntiviral ResponseAntiviral TherapyAutomobile DrivingCCL2 geneCCR1 geneCell modelCellsCessation of lifeChildChildhoodChildhood InjuryClinicalClinical DataCommunicationCoupledCritically ill childrenDataData AnalysesDevelopmentDiseaseDisease ProgressionEpidemicEpithelial CellsEquilibriumExperimental DesignsFosteringFunctional disorderGene ExpressionGoalsIRF3 geneITGAX geneImmune responseImmunologic MemoryImpairmentInfectionInfection ControlInflammasomeInflammatoryInflammatory ResponseInfluenzaInfluenza A virusInnate Immune ResponseInterferon-alphaInterferon-betaInterleukin-1 betaInterleukin-18InterventionKnowledgeLaboratory ProceduresLifeLungLung InflammationMediatingMedicalMentorsMorbidity - disease rateMusPathogenesisPathway interactionsPatientsPeripheralPhysiciansPneumoniaPopulationPreventionProcessProductionReceptor ActivationReceptor SignalingRegulationResearchRespiratory Tract InfectionsRiskRoleScientistSignal TransductionSupportive careTestingTherapeuticTissuesTrainingTraining ProgramsTranslatingViralViral PneumoniaViral Respiratory Tract InfectionVirusVirus DiseasesVirus ReplicationVulnerable Populationsalveolar epitheliumalveolar type II cellbasecell typechemokine receptorclinically relevantcomorbiditydesigngamma-Chemokinesin vitro Modelin vivoinfluenza infectionlaboratory experiencelung developmentlung injurymature animalmonocytemonocyte chemoattractant protein 1 receptormortalitymouse modelnovelnovel therapeuticspandemic diseasepatient populationpediatric patientspreventreceptorreceptor expressionrecruitresponseskillstooltranscriptometranscriptome sequencing
项目摘要
PROJECT SUMMARY
The broad objectives of this K08 proposal are two-fold: (1) to foster the development of essential scientific and
professional skills that will allow the candidate, Dr. Bria Coates, to achieve her long-term goal of becoming an
independent physician-scientist concentrating on the development of acute lung injury in children with viral
respiratory infections and seeking solutions that could be translated for therapeutic benefit to critically ill
children, and (2) to investigate mechanisms that regulate the immune response to influenza A virus (IAV) and
contribute to increased morbidity and mortality in the pediatric patient population. Through laboratory
experience, didactic coursework, and the collaborative process, Dr. Coates will gain expertise in experimental
design, laboratory procedures, data analysis, and scientific communication. Dr. Coates and her mentor, Dr.
Karen Ridge, have designed a specific training plan that will afford Dr. Coates new knowledge and research
skills in the pathophysiology of acute lung inflammation and acute respiratory distress syndrome (ARDS),
which is a lung condition that causes tremendous morbidity and mortality in young patients with viral
respiratory infections. Importantly, recent clinical data thwart the long-standing dogma that children with
influenza have increased morbidity and mortality due to impaired viral clearance. Our preliminary data identify
an altered innate immune response in IAV-infected juvenile mice as a critical parameter in disease
progression. Specifically, we show that increased lung injury in IAV-infected juvenile mice is associated with
robust activation of the NOD-like receptor (NLR) proteins NOD2 and the NLRP3, resulting in increased IFNα/β
and IL-1β/18 levels, respectively, that persist beyond viral elimination. In addition, juvenile lungs produce more
MCP-1 and recruit more inflammatory monocytes during IAV infection, which then perpetuates NOD2 and
NLRP3 activation. We observe that juvenile recruited monocytes are uniquely inflammatory, and prevention of
their recruitment during IAV infection protects juvenile mice from IAV-mediated lung injury. We hypothesize
that age-specific, cell autonomous differences in the innate immune response to IAV contribute to the
robust and sustained activation of NLR proteins and exacerbate IAV-induced lung injury in juvenile
mice. We have formulated three interrelated specific aims to study the regulation of monocyte recruitment and
NLR signaling in both in vivo and in vitro models of juvenile IAV-induced lung injury. Specific Aim 1:
Investigate the age-specific mechanisms that modulate the activation of NLR proteins in response to IAV
infection and contribute to IAV-induced acute lung injury. Specific Aim 2: Determine whether recruited
monocytes are required for IAV-mediated acute lung injury in juvenile mice. Specific Aim 3: Identify cell
autonomous differences in juvenile IAV infection that may drive age-specific inflammatory responses.
Completion of these aims will provide a rigorous training program for Dr. Coates and uncover mechanisms
driving acute lung injury in children with viral respiratory infections.
项目摘要
K 08提案的广泛目标有两个方面:(1)促进基本科学和技术的发展,
专业技能,使候选人,布里亚科茨博士,实现她的长期目标,成为一个
专注于病毒性肺炎儿童急性肺损伤发展的独立医生-科学家
呼吸道感染和寻求解决方案,可以转化为治疗效益,以危重病
儿童,以及(2)研究调节对甲型流感病毒(IAV)的免疫应答的机制,
导致儿科患者人群的发病率和死亡率增加。通过实验室
经验,教学课程,和合作过程中,博士科茨将获得专业知识,在实验
设计、实验室程序、数据分析和科学交流。科茨博士和她的导师,博士。
凯伦里奇设计了一个具体的培训计划,将提供科茨博士新的知识和研究
急性肺部炎症和急性呼吸窘迫综合征(ARDS)的病理生理学技能,
这是一种肺部疾病,在年轻的病毒性肺炎患者中引起巨大的发病率和死亡率。
呼吸道感染重要的是,最近的临床数据推翻了长期以来的教条,即儿童
流感由于病毒清除受损而增加了发病率和死亡率。我们的初步数据表明
在IAV感染的幼年小鼠中改变的先天免疫应答作为疾病的关键参数
进展具体地说,我们发现,在IAV感染的幼年小鼠中,肺损伤的增加与
NOD样受体(NLR)蛋白NOD 2和NLRP 3的强烈激活,导致IFNα/β增加
和IL-1β/18水平,持续超过病毒消除。此外,青少年的肺产生更多的
在IAV感染期间,MCP-1和招募更多的炎性单核细胞,然后使NOD 2和
NLRP 3激活。我们观察到幼年募集的单核细胞是唯一的炎症细胞,
它们在IAV感染期间的募集保护幼年小鼠免受IAV介导的肺损伤。我们假设
年龄特异性,细胞自主差异的先天免疫反应,以IAV有助于
NLR蛋白的持续激活并加重IAV诱导的青少年肺损伤
小鼠我们制定了三个相互关联的具体目标来研究单核细胞募集的调节,
幼年IAV诱导的肺损伤的体内和体外模型中的NLR信号传导。具体目标1:
研究年龄特异性调节IAV应答中NLR蛋白激活的机制
感染并导致IAV诱导急性肺损伤。具体目标2:确定是否招募
单核细胞是幼年小鼠中IAV介导的急性肺损伤所必需的。具体目标3:识别细胞
青少年IAV感染的自主差异可能驱动年龄特异性炎症反应。
完成这些目标将为科茨博士提供严格的培训计划,并揭示其机制
小儿病毒性呼吸道感染致急性肺损伤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bria M Coates其他文献
Bria M Coates的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bria M Coates', 18)}}的其他基金
Elucidating the role of type I interferon signaling and macrophage-derived inflammation in the juvenile host with viral pneumonia
阐明 I 型干扰素信号传导和巨噬细胞衍生炎症在病毒性肺炎幼年宿主中的作用
- 批准号:
10651426 - 财政年份:2023
- 资助金额:
$ 16.12万 - 项目类别:
Pathophysiology of Influenza A Virus-induced Lung Injury in Juveniles
甲型流感病毒引起的青少年肺损伤的病理生理学
- 批准号:
9756467 - 财政年份:2018
- 资助金额:
$ 16.12万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 16.12万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 16.12万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 16.12万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 16.12万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 16.12万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 16.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 16.12万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 16.12万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 16.12万 - 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
- 批准号:
MR/Y000404/1 - 财政年份:2023
- 资助金额:
$ 16.12万 - 项目类别:
Fellowship














{{item.name}}会员




